4/A

OWNERSHIP DOCUMENT

Company: SUPERNUS PHARMACEUTICALS, INC.
Filed: January 13, 2023
Period of Report: March 14, 2022
Accession Number: 0001104659-23-003861

View Document ↗ View on SEC.gov ↗